Peptic Ulcer Research Today is a free monthly online journal that collates and summarizes the latest research about Peptic Ulcer, including details on helicobacter pylori, diet, symptoms, treatment.

Volume 2 (2005), Issue 6 (June)

1. Synthesis and antioxidant, anti-inflammatory and gastroprotector activities of anethole and related compounds.
   Bioorg Med Chem, 13(13): 4353-8. [Abstract] [Full-text]
2. The protective effects of rutaecarpine on gastric mucosa injury in rats.
   Planta Med, 71(5): 416-9. [Abstract] [Full-text]
3. Host TNF-alpha-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection.
   Am J Gastroenterol, 100(6): 1274-82. [Abstract] [Full-text]
4. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
   Am J Gastroenterol, 100(6): 1243-50. [Abstract] [Full-text]
5. Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.
   Aliment Pharmacol Ther, 21(11): 1331-9. [Abstract] [Full-text]
6. Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
   Aliment Pharmacol Ther, 21: 99-104. [Abstract] [Full-text]
7. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
   Aliment Pharmacol Ther, 21: 67-72. [Abstract] [Full-text]
8. Effect of orally administered omeprazole on abomasal luminal pH in dairy calves fed milk replacer.
   J Vet Med A Physiol Pathol Clin Med, 52(5): 238-43. [Abstract] [Full-text]
9. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients.
   Aliment Pharmacol Ther, 21(12): 1459-65. [Abstract] [Full-text]
10. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
    Aliment Pharmacol Ther, 21(12): 1419-24. [Abstract] [Full-text]
11. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Aliment Pharmacol Ther, 21(12): 1411-8. [Abstract] [Full-text]
12. Duodenal ulcer in South Africa: home-pounded versus milled maize.
    J Gastroenterol Hepatol, 20(7): 1008-11. [Abstract] [Full-text]
13. Events at the host-microbial interface of the gastrointestinal tract IV. The pathogenesis of Helicobacter pylori persistence.
    Am J Physiol Gastrointest Liver Physiol, 289(1): G8-12. [Abstract] [Full-text]
14. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers.
    Am J Physiol Gastrointest Liver Physiol, 289(1): G138-45. [Abstract] [Full-text]
15. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    J Pharmacol Exp Ther, 314(1): 302-9. [Abstract] [Full-text]
16. Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs.
    J Pharm Pharmacol, 57(7): 923-7. [Abstract] [Full-text]
17. Is it possible to reduce endoscopy workload using age, alarm symptoms and H. pylori as predictors of peptic ulcer and oesophagogastric cancers?
    Dig Liver Dis, 37(7): 526-32. [Abstract] [Full-text]
18. Peptic ulcer disease in dyspeptic patients with ischemic heart disease: search and treat?
    Z Gastroenterol, 43(6): 581-6. [Abstract] [Full-text]

© 2004-2008 Peptic Ulcer Research Today. All Rights Reserved.